title: Meshology: a fast-growing field involving mesh and/or tape removal procedures and their outcomes.
abstract: Stress urinary incontinence and pelvic organ prolapse are two of the commonest conditions affecting women today. It is associated with significant compromise to quality of life. Through the years, there has been an evolution of technique and graft material to augment repairs for durability. Transvaginal placements of synthetic mid-urethral slings and vaginal meshes have largely superseded traditional tissue repairs in the current era because of presumed efficacy and ease of implant with device 'kits'. The use of synthetic material has generated novel complications, including mesh extrusion, pelvic and vaginal pain and mesh contraction. In this review, our aim is to discuss the management and outcomes associated with mesh removal. In addition, we will briefly review the safety communications issued by the US FDA on transvaginal mesh placement and a new classification system for complications arising from the use of synthetic graft endorsed by both the International Continence Society and International Urogynecological Association.
authors.affiliation: Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9110, USA.
authors.forename: Dominic
authors.initials: D
authors.lastname: Lee
authors.forename: Chasta
authors.initials: C
authors.lastname: Bacsu
authors.forename: Philippe E
authors.initials: PE
authors.lastname: Zimmern
mesh_terms: D006801:Humans; D011183:Postoperative Complications / Q000209:etiology; D012735:Sexual Dysfunction, Physiological / Q000503:physiopathology; D053825:Suburethral Slings; D013526:Surgical Mesh / Q000009:adverse effects; D053832:Surgical Tape; D016896:Treatment Outcome
keywords: US FDA; complications; mid-urethral slings; outcomes; pelvic organ prolapse; stress urinary incontinence; vaginal mesh